{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:49:43Z","timestamp":1772178583886,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T00:00:00Z","timestamp":1363651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059419","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T17:04:37Z","timestamp":1363712677000},"page":"e59419","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Functional Impact of ABCB1 Variants on Interactions between P-Glycoprotein and Methadone"],"prefix":"10.1371","volume":"8","author":[{"given":"Chin-Chuan","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Han","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ning","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yow-Wen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"ref1","first-page":"20","article-title":"Heroin dependence","volume":"103","author":"R Brown","year":"2004","journal-title":"WMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"RD Bruce","year":"2010","journal-title":"Int J Drug Policy"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jsat.2008.11.004","article-title":"The effect of methadone maintenance on positive outcomes for opiate injection drug users","volume":"37","author":"KF Corsi","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11597520-000000000-00000","article-title":"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals","volume":"72","author":"JM Tetrault","year":"2012","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism","volume":"12","author":"Y Li","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/156802611795371288","article-title":"Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance","volume":"11","author":"SL Mercer","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","article-title":"ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals","volume":"80","author":"JK Coller","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"S Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Crettol S, Deglon JJ, Besson J, Croquette-Krokar M, Hammig R, <etal>et al<\/etal>.. (2008) No influence of ABCB1 haplotypes on methadone dosage requirement. Clin Pharmacol Ther 83: 668\u2013669; author reply 669\u2013670.","DOI":"10.1038\/sj.clpt.6100305"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"CC Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","article-title":"ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence","volume":"17","author":"O Levran","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1472-8206.1999.tb00009.x","article-title":"The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac","volume":"13","author":"R Bouer","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice","volume":"173","author":"JS Wang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"N Tournier","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2003.02053.x","article-title":"The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone","volume":"57","author":"ED Kharasch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11095-007-9251-2","article-title":"Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar","volume":"24","author":"I Ortega","year":"2007","journal-title":"Pharm Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1211\/0022357022782","article-title":"Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat","volume":"56","author":"M Rodriguez","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation","volume":"98","author":"HE Hassan","year":"2009","journal-title":"J Pharm Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood-brain barrier","volume":"10","author":"DJ Begley","year":"2004","journal-title":"Curr Pharm Des"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: structure, function and role in chemoresistance","volume":"9","author":"FJ Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-14541-4_6","article-title":"P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations","volume":"201","author":"I Cascorbi","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"M Dean","year":"2001","journal-title":"Genome Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1021\/bi972709x","article-title":"HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter","volume":"37","author":"CG Lee","year":"1998","journal-title":"Biochemistry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"AH Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4088\/JCP.v62n1010","article-title":"Repeated ingestion of grapefruit juice does not alter clozapine\u2019s steady-state plasma levels, effectiveness, and tolerability","volume":"62","author":"HY Lane","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.canlet.2005.06.051","article-title":"Implications of genetic polymorphisms in drug transporters for pharmacotherapy","volume":"234","author":"R Kerb","year":"2006","journal-title":"Cancer Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance","volume":"75","author":"C Marzolini","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/hmg\/ddi494","article-title":"ABCB1\/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach","volume":"15","author":"GT Ho","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mcp.2001.117412","article-title":"Identification of functionally variant MDR1 alleles among European Americans and African Americans","volume":"70","author":"RB Kim","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1023\/A:1020433422259","article-title":"Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin","volume":"19","author":"M Horinouchi","year":"2002","journal-title":"Pharm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00008571-200208000-00004","article-title":"Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations","volume":"12","author":"K Tang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jac\/dkq209","article-title":"Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines","volume":"65","author":"WF Bierman","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00002030-200006160-00034","article-title":"Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture","volume":"14","author":"MD Perloff","year":"2000","journal-title":"AIDS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00002030-200305020-00023","article-title":"Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein","volume":"17","author":"D Vishnuvardhan","year":"2003","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10637-010-9496-1","article-title":"YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway","volume":"29","author":"CC Hung","year":"2011","journal-title":"Invest New Drugs"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1345\/aph.1A447","article-title":"Interactions between recreational drugs and antiretroviral agents","volume":"36","author":"T Antoniou","year":"2002","journal-title":"Ann Pharmacother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11481-006-9034-2","article-title":"MDR- and CYP3A4-mediated drug-drug interactions","volume":"1","author":"D Pal","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.lfs.2005.12.010","article-title":"MDR- and CYP3A4-mediated drug-herbal interactions","volume":"78","author":"D Pal","year":"2006","journal-title":"Life Sci"},{"key":"ref39","first-page":"954","article-title":"Methadone inhibits rhodamine123 transport in Caco-2 cells","volume":"29","author":"E Stormer","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"C Dagenais","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2885.2012.01390.x","article-title":"The effect of P-Glycoprotein on methadone hydrochloride flux in equine intestinal mucosa","volume":"36","author":"RL Linardi","year":"2013","journal-title":"J Vet Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00002030-199905280-00012","article-title":"Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone","volume":"13","author":"FL Altice","year":"1999","journal-title":"AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1975173258","article-title":"Disposition of methadone in methadone maintenance","volume":"17","author":"E Anggard","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.12.69","article-title":"UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients","volume":"13","author":"JN Tian","year":"2012","journal-title":"Pharmacogenomics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e19527","DOI":"10.1371\/journal.pone.0019527","article-title":"Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response","volume":"6","author":"F Fonseca","year":"2011","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(02)07276-8","article-title":"Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study","volume":"359","author":"J Fellay","year":"2002","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328011d7c1","article-title":"Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia","volume":"21","author":"S Rodriguez-Novoa","year":"2007","journal-title":"AIDS"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/dkp317","article-title":"Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors","volume":"64","author":"PL Anderson","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10408363.2011.620601","article-title":"Methadone: a review of drug-drug and pathophysiological interactions","volume":"48","author":"BM Kapur","year":"2011","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:03:18Z","timestamp":1540306998000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059419"}},"subtitle":[],"editor":[{"given":"Luis Eduardo M.","family":"Quintas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059419","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}